fda d.i.s.c.o. burst edition: fda approvals of tivdak (tisotumab vedotin-tftv) for recurrent or m...
Published 2 months ago • 34 plays • Length 5:01
Download video MP4
Download video MP3
Similar videos
-
4:44
safety and efficacy profile of tisotumab vedotin for recurrent or metastatic cervical cancer
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
8:23
ctsi watch and learn: fda 101: a primer on ides
-
1:10
results for tisotumab vedotin in patients with metastatic or recurrent cervical cancer
-
3:06
update on the efficacy and safety of the libretto-531 trial
-
1:00:08
hifu for prostate cancer finally gets the fda nod. dr.stephen scionti tells what to expect.
-
7:07
translatum medicus moves forward with plans to engage fda
-
2:16
fda considerations for approval of therapies in gi cancers
-
52:22
immunotherapy: car-t cells - stephan grupp, md, phd
-
7:00
how to treatment plan for dental implants using dexis 3d ct scans
-
1:04:20
master class - fda pre-submissions
-
0:52
optimos cystotome (fda, kfda)
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
31:18
fda, cdc experts: what physicians need to know about tecovirimat (tpoxx) for treatment of monkeyp...
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
-
2:27
edap seeks fda approval of its ablatherm hifu treatment for prostate cancer
-
3:06
measuring tgsav: htee by imacor
-
0:32
jason efstathiou, md - 9/15/19 everyday amazing healthcare professional
-
2:27
eleni efstathiou, md, phd, considers the role of precision medicine in prostate cancer
-
1:09
dr. tolaney on the advantages of ctdna versus tissue biopsy in breast cancer
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
Clip.africa.com - Privacy-policy